Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2024, After Market Close on July 2, 2024

Company Overview - Avid Bioservices, Inc. is a dedicated biologics contract development and manufacturing organization (CDMO) focused on improving patient lives by providing high-quality services to biotechnology and pharmaceutical companies [3] - The company has over 30 years of experience in producing biologics and offers a comprehensive range of services including CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submissions support [3] Financial Reporting - Avid Bioservices will report its financial results for the quarter and fiscal year ended April 30, 2024, on July 2, 2024, after market close [1] - A webcast will be hosted at 1:30 PM Pacific Time (4:30 PM Eastern Time) where senior management will discuss the financial results and recent corporate developments [1]